Scarica l'app Stockscreener
30.18
1.31%
0.39
Pre-mercato:
30.28
0.10
+0.33%
Quidelortho Corporation Borsa (QDEL) Ultime notizie
What Makes QuidelOrtho (QDEL) a New Buy Stock - Nasdaq
Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term - Yahoo Finance
Should Value Investors Buy QuidelOrtho (QDEL) Stock? - Yahoo Finance
This QuidelOrtho Insider Increased Their Holding In The Last Year - simplywall.st
QuidelOrtho Declares that its Molecular Diagnostics Approach will be Refocused - MSN
Lex seeks FDA clearance ahead of $100M Quidelortho takeover - BioWorld MedTech
QuidelOrtho set to buy LEX Diagnostics for $100m after FDA approval trigger - Cambridge Independent
QuidelOrtho Corp (QDEL) Trading 4% Higher on Jun 9 - GuruFocus
QuidelOrtho seeks FDA approval to complete acquisition of LEX Diagnostics - Mugglehead Magazine
QuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.
Transcript : QuidelOrtho Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 08 - MarketScreener
Transcript : QuidelOrtho Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-04-2025 08 - marketscreener.com
QuidelOrtho Corp (QDEL) Stock Price Down 2.92% on Jun 2 - GuruFocus
QuidelOrtho to discontinue Savanna platform development - MSN
QuidelOrtho (QDEL) to Acquire LEX Diagnostics Amid Strategic Shi - GuruFocus
QuidelOrtho shifts focus with LEX Diagnostics deal, drops Savanna By Investing.com - Investing.com South Africa
Transcript : QuidelOrtho CorporationSpecial Call - marketscreener.com
QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics | QDEL Stock News - GuruFocus
QuidelOrtho (QDEL) Shifts Strategy, Plans to Acquire LEX Diagnos - GuruFocus
QuidelOrtho to exit Savanna platform development (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho shifts focus with LEX Diagnostics deal, drops Savanna - Investing.com
QuidelOrtho announces a refocusing of its molecular diagnostics strategy - TipRanks
QuidelOrtho (QDEL) to acquire full ownership of LEX Diagnostics, announces strategy to accelerate growt - StreetInsider
QuidelOrtho Makes Major Molecular Diagnostics Pivot: $100M LEX Acquisition to Replace Savanna Platform - Stock Titan
Why QuidelOrtho (QDEL) is a Top Momentum Stock for the Long-Term - sharewise
Here's Why QuidelOrtho (QDEL) is a Strong Growth Stock - Yahoo Finance
QuidelOrtho Corp (QDEL) Stock Price Down 3.63% on May 29 - GuruFocus
QuidelOrtho Stockholders Approve Equity Plan Changes - TipRanks
Luxfer, LGI Homes, QuidelOrtho, Dentsply Sirona, and AdaptHealth Stocks Trade Up, What You Need To Know - Yahoo Finance
10,269 Shares in QuidelOrtho Co. (NASDAQ:QDEL) Acquired by BNP Paribas Financial Markets - Defense World
QuidelOrtho’s SWOT analysis: diagnostics firm’s stock faces pivotal year - Investing.com
QuidelOrtho’s SWOT analysis: diagnostics firm’s stock faces pivotal year By Investing.com - Investing.com Canada
Asian Hospital, Faridabad Becomes the First in the City to Launch Total Lab Automation with QuidelOrtho - APN News
QuidelOrtho to Participate in Upcoming June 2025 Investor Conferences - BioSpace
QuidelOrtho to Participate in Upcoming Investor Conferences | QDEL Stock News - GuruFocus
Asian Hospital, Faridabad introduces total lab automation with QuidelOrtho - IndiaMedToday
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - MSN
QuidelOrtho Management to Present at William Blair and Jefferies Healthcare Conferences Next Month - Stock Titan
Asian Hospital in Faridabad launches total lab automation in partnership with QuidelOrtho - BioSpectrum India
QuidelOrtho Corp (QDEL) Stock Price Down 3.32% on May 19 - GuruFocus
Captrust Financial Advisors Boosts Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Ameriprise Financial Inc. Has $10.84 Million Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
0.54%
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):